Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer

CONCLUSIONS: Our results predict and validate the function of FOXA1 in promoting EMT and the progression of disease in EOC. Targeting FOXA1 may improve the sensitivity of EOC treatment.PMID:36393971 | PMC:PMC9646314 | DOI:10.1155/2022/9328972

Source: Disease Markers - November 17, 2022 Category: Laboratory Medicine Authors: Kai Wang Chenan Guan Junhui Yu Xing Chen Xianwen Shang Shuangshuang Mei Xingjun Feng Lingzhi Zheng Source Type: research